When activated by its target, the newly characterized molecule rips the genome apart, a lethal move that researchers can ...

Detailed price information for Editas Medicine (EDIT-Q) from The Globe and Mail including charting and trades.

Intellia Therapeutics (NTLA) is a clinical-stage biotech firm working on CRISPR-based treatments that try to edit genes ...

Individuals that share the same deletion of a portion of chromosome 16 are at risk of developing neurodevelopmental disorders ...

It is natural to wonder whether the world is on the cusp of a nightmarish age of AI -enabled bioterrorism—and, if so, what ...

The gene-editing drug is designed to treat patients with elevated low-density lipoprotein cholesterol or serum triglycerides.

Stuart Orkin and Swee Lay Thein shared a Breakthrough Prize in Life Sciences for their research on genetic causes of sickle ...

Plant abiotic stresses such as salinity and drought significantly impede plant growth and agricultural yield globally.

CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the first quarter ended March 31, 2026. “The first ...

A Hiroshima-University-led research team has discovered a key gene responsible for the initiation of gemma development, ...